HAVN Life Sciences Inc. (HAVLF)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: May 27, 2025
HAVN Life Sciences Market Cap
HAVN Life Sciences has a market cap or net worth of $621.26 thousand as of May 30, 2025. Its market cap has decreased by -91.30% in one year.
Market Cap
621.26K
Enterprise Value
630.11K
Revenue
440.11K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 8, 2020, HAVN Life Sciences's market cap has decreased from 30.90M to 621.26K, a decrease of -97.99%. That is a compound annual growth rate of -70.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2023 | 621.26K | -28.86% |
| Dec 30, 2022 | 873.31K | -94.89% |
| Dec 31, 2021 | 17.10M | -71.47% |
| Dec 31, 2020 | 59.94M | 93.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.60B |
| Veradigm | 730.27M |
| Nika Pharmaceuticals | 667.04M |
| Tian'an Technology Group | 614.49M |
| Elite Pharmaceuticals | 576.87M |
| Glass House Brands | 452.99M |
| CytoDyn | 427.05M |
| Northwest Biotherapeutics | 394.36M |